A glance at the weighted underlying holdings of the SPDR S&P Health Care Equipment ETF (Symbol: XHE) reveals an impressive 10.1% of holdings on a weighted basis have experienced insider buying within the past six months.
Zimmer Biomet Holdings Inc (Symbol: ZBH), constituting 1.57% of the SPDR S&P Health Care Equipment ETF (Symbol: XHE), has seen 7 directors and officers purchase shares in the past six months, as per the recent Form 4 data. The ETF holds a total of $4,736,845 worth of ZBH, making it the #34 largest holding.
The significant insider buying activity at ZBH is indicative of a bullish sentiment among company insiders. Arthur J. Higgins, Betsy J. Bernard, Michael W. Michelson, Robert Hagemann, Sreelakshmi Kolli, Christopher B. Begley, and Syed A. Jafry’s recent share purchases further underscore the positive outlook for the company.
ZBH — last trade: $121.84 — Recent Insider Buys:
Purchased | Insider | Title | Shares | Price/Share | Value |
---|---|---|---|---|---|
08/23/2023 | Arthur J. Higgins | Director | 1,000 | $115.61 | $115,613 |
DENTSPLY SIRONA Inc (Symbol: XRAY), holding the #39 largest position among components of the SPDR S&P Health Care Equipment ETF (Symbol: XHE), exhibits 3 directors and officers who have recently filed Form 4’s indicating purchases. The ETF holds $4,585,884 worth of XRAY, representing approximately 1.52% of the ETF’s total assets at last check.
The recent insider buying activity observed at XRAY denotes a bullish stance among company insiders. The share purchases by Glenn Coleman, Simon D. Campion, and Gregory T. Lucier accentuate the positive sentiment surrounding the company.
XRAY — last trade: $32.67 — Recent Insider Buys:
Purchased | Insider | Title | Shares | Price/Share | Value |
---|---|---|---|---|---|
11/20/2023 | Glenn Coleman | Executive VP & CFO | 10,000 | $29.70 | $297,000 |
10 ETFs With Stocks That Insiders Are Buying »
Also see:
SHAG market cap history
RIOT Average Annual Return
FWP shares outstanding history
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.